14 results
424B5
IPHA
Innate Pharma
6 Feb 24
Prospectus supplement for primary offering
5:00pm
or grantor trusts;
persons that hold our ADSs as part of a “hedging,” “integrated,” “wash sale” or “conversion” transaction or as a position
424B5
IPHA
Innate Pharma
26 Apr 23
Prospectus supplement for primary offering
4:01pm
trusts;
persons that hold our ordinary shares or ADSs as part of a “hedging,” “integrated,” “wash sale” or “conversion” transaction or as a position
424B5
IPHA
Innate Pharma
3 May 22
Prospectus supplement for primary offering
4:36pm
that hold our ordinary shares or ADSs as part of a “hedging,” “integrated,” “wash sale” or “conversion” transaction or as a position in a “straddle
20-F
2kv6d8
24 Apr 20
Annual report (foreign)
10:43am
424B4
3b48p5ogmk7ygogg5
18 Oct 19
Prospectus supplement with pricing info
4:08pm
F-1/A
lhwdlumn8042d
4 Oct 19
Registration statement (foreign) (amended)
4:56pm
F-1
upma70y0
20 Sep 19
Registration statement (foreign)
4:08pm
DRS/A
lgh5e6aq1k
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
pqpq3
19 Jul 19
Draft registration statement (amended)
12:00am
DRS
5r7v7b
10 Jun 19
Draft registration statement
12:00am
- Prev
- 1
- Next